SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: blankmind who wrote (4267)1/4/1998 10:41:00 AM
From: RT  Read Replies (1) of 23519
 
blankmind,

The report centered around men who were suffering from impotence and that there was now an available treatment. The doctor in the report mentioned that in the past it was believed impotence was a phycological problem, and that now they have recognized the majority of impotence was in fact a physicial problem ex., diabetes, vascular disease, and trama.
They then displayed each products on a table and how each one was administered. They correctly described how the muse pellet was inserted into the penis. During one of the monologs you could see a doctor in his office demonstrating the product muse to a patient.
No company officials were interviewed.
At the end they featured a man of 40 who was suffering from impotence and that he was on the experimental pill Viagara. He reported that his sex life had been restored to normal.
Overall it was a well done unbiased piece. My hat goes off to WGNX.

RT
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News